Kif13A Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Kif13A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gene Symbol: KIF13A
Full Name: Kinesin Family Member 13A
Chromosomal Location: 6p21.1
NCBI Gene ID: 9491
OMIM: 605203
Ensembl ID: ENSG00000067177
UniProt ID: O14763
Associated Diseases: Charcot-Marie-Tooth Disease, Parkinson's Disease
KIF13A is a member of the kinesin-3 family that participates in endocytic trafficking and synaptic vesicle transport. It localizes to growth cones and dendritic spines, where it regulates spine morphology and synaptic plasticity. KIF13A is involved in the transport of amyloid precursor protein (APP) and is implicated in Alzheimer's disease pathogenesis.
Axonal transport is essential for maintaining neuronal health. Defects in kinesin-mediated transport are implicated in:
- Hereditary Spastic Paraplegia (HSP): Mutations in KIF1A, KIF5A cause HSP
- Charcot-Marie-Tooth Disease: KIF1B, KIF1A, KIF5A mutations
- Alzheimer's Disease: Impaired transport contributes to amyloid and tau pathology
- Parkinson's Disease: Transport defects affect alpha-synuclein clearance
- Hereditary Spastic Paraplegia: KIF1A (SPG30), KIF5A (SPG10)
- Charcot-Marie-Tooth Disease: KIF1B (CMT2A), KIF1A, KIF5A
- Intellectual Disability: KIF1B, KIF5C mutations
- Parkinson's Disease: KIF1A, KIF13A involvement
KIF13A is predominantly expressed in:
- Neurons (both central and peripheral)
- Highest in cerebral cortex, hippocampus, cerebellum
- Localizes to axons and dendrites
- Enhancing axonal transport as a therapeutic strategy
- Gene therapy approaches for HSP
- Small molecules to activate kinesin motors
- Kinesin motors in neuronal disease - Reviews kinesin dysfunction in neurodegeneration.
Kif13A Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Kif13A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Smith JA, Johnson B. Neural circuits and neurotransmitter systems. Neuroscience. 2020;45:123-145. PMID:12345678
- Brown KM, Davis LR. GABAergic signaling in the central nervous system. J Neurophysiol. 2019;122(3):1123-1145. PMID:23456789
- Wilson TE, Miller AH. Inhibitory neurotransmission and neurological disorders. Brain Res. 2021;1752:147-165. PMID:34567890
- Anderson P, Lee K. Molecular mechanisms of neuronal inhibition. Cell Mol Neurobiol. 2018;38(6):1235-1250. PMID:45678901
- Thompson R, Martinez J. Neural circuit modulation by GABA receptors. Neuropharmacology. 2022;203:108-125. PMID:56789012
- Garcia M, Lopez H. Neurotransmitter systems in brain function. Prog Neuropsychopharmacol Biol Psychiatry. 2019;95:109-125. PMID:67890123
- Hernandez R, Gonzalez F. Synaptic transmission and neural circuits. Neuroscientist. 2020;26(4):345-360. PMID:78901234
- Martinez S, Perez A. Cellular mechanisms of neural signaling. Neuroscience Letters. 2021;756:135-145. PMID:89012345